产品封面图

Shikari® (S-AIR) Anti-Inflixim

ab biosimilar ELISA w/confirmation
收藏
  • ¥10700
  • MATRiKs Biotek
  • 土耳其
  • INF-QNS-REMS
  • 2025年08月29日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 库存

      5

    • 供应商

      西宝生物400-021-8158

    • 规格

      96T

    Enzyme immunoassay for the quantitative determination of antibodies to Infliximab-biosimilar (Remsima®) in serum and plasma with confirmation.

    SHIKARI® Quantitative Antibodies to Infliximab Biosimilar ELISA has been especially developed for the quantitative analysis of antibodies to infliximab biosimilar in serum and plasma samples. This kit is optimized with Remsima®.

    Infliximab (Remsima®) was associated to the development of anti- Infliximab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Remsima®. This might lead to severe complications.This kit can be efficiently used for monitoring anti- Infliximab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti- Infliximab antibodies.

    All SHIKARI® ELISA kits are suitable for biosimilar work. 

    All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • Models of Inflammation: Carrageenan Air Pouch

      :147–153.    Jain, M. and Parmar, H.S. 2011. Evaluation of antioxidative and anti‐inflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation

    • Immunostaining with Anti-Digoxigenin Alkaline Phosphatase

      Ususally 1:1000 (v/v) in PBS.  Wash in PBS 2' x3. Equilibrate slides in Buffer 1, RT x 5'. Incubate slides in Blocking Buffer, RT x 30' Incubate  with anti-Dig-AP conjugate  (1:2000 in Blocking buffer.), 2 hrs. RT, or o.n. at 4ºC.

    • Immunostaining with Anti-Digoxigenin Alkaline Phosphatase

      Ususally 1:1000 (v/v) in PBS.  Wash in PBS 2' x3. Equilibrate slides in Buffer 1, RT x 5'. Incubate slides in Blocking Buffer, RT x 30' Incubate  with anti-Dig-AP conjugate  (1:2000 in Blocking buffer.), 2 hrs. RT, or o.n. at 4ºC.

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥10300
    西宝生物科技(上海)股份有限公司
    2025年08月29日询价
    ¥5728
    北京达科为生物技术有限公司
    2025年07月01日询价
    ¥8388
    普健生物(武汉)科技有限公司
    2025年07月12日询价
    ¥8400
    武汉益普生物科技有限公司
    2025年12月21日询价
    询价
    上海一研生物科技有限公司
    2025年07月13日询价
    Shikari® (S-AIR) Anti-Infliximab biosimilar ELISA w/confirmation
    ¥10700